Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement
Convertible Notes Indentures
On March 20, 2026, Ormat Technologies, Inc. (the
“Company”) completed its previously announced offering of $1 billion aggregate principal amount of convertible senior notes,
consisting of (i) $825 million aggregate principal amount of 1.50% Series A Convertible Senior Notes due 2031 (the “Series A Notes”)
and (ii) $175 million aggregate principal amount of 0.00% Series B Convertible Senior Notes due 2031 (the “Series B Notes”
and, together with the Series A Notes, the “Notes”), in each case, including the exercise in full of the initial purchasers’
options to purchase an additional $100 million and $25 million of Series A Notes and Series B Notes, respectively.
The Series A Notes were issued pursuant to an
indenture, dated March 20, 2026 (the “Series A Notes Indenture”), between the Company and U.S. Bank Trust Company, National
Association, as trustee (the “Trustee”).
The Series B Notes were issued pursuant to an
indenture, dated March 20, 2026 (the “Series B Notes Indenture” and, together with the Series A Indenture, the “Indentures”),
between the Company and the Trustee.
Each series of Notes will mature on March 15,
2031, unless earlier converted, redeemed or repurchased in accordance with its terms prior to such date. For the Series A Notes, interest
will accrue at a rate of 1.50% per year and will be payable semiannually in arrears on March 15 and September 15 of each year, beginning
on September 15, 2026. The Series B Notes will not bear regular interest, and the principal amount of the Series B Notes will not accrete.
The Company will pay special interest, if any, on the Series B Notes as set forth in the Series B Notes Indenture.
The Notes of each series are convertible into
cash up to the aggregate principal amount of the Notes to be converted and cash, shares of the Company’s common stock (“Common
Stock”) or a combination of cash and shares of Common Stock, at the Company’s election, in respect of the remainder, if any,
of the Company’s conversion obligation in excess of the aggregate principal amount of the Notes being converted. The initial conversion
rate for the Series A Notes will be 7.1225 shares of Common Stock for each $1,000 principal amount of Series A Notes (equivalent to an
initial conversion price of approximately $140.40 per share of Common Stock), and the initial conversion rate for the Series B Notes will
be 7.1225 shares of Common Stock for each $1,000 principal amount of Series B Notes (equivalent to an initial conversion price of approximately
$140.40 per share of Common Stock). The conversion rate of each series of Notes, and thus the conversion price of such series of Notes,
may be adjusted under certain circumstances, including in connection with conversions made following a fundamental change or a redemption
notice and under other circumstances, in each case as set forth in the applicable Indenture.
Prior to 5:00 p.m., New York City time, on the
business day immediately preceding November 15, 2030, each series of Notes will be convertible only under the following circumstances:
(1) during any calendar quarter commencing after the calendar quarter ending on June 30, 2026 (and only during such calendar quarter),
if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during the period of 30
consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than
or equal to (x) prior to March 15, 2030, 150% and (y) on or after March 15, 2030, 130%, in each case, of the conversion price of such
series of Notes on each applicable trading day; (2) during the five consecutive business day period immediately after any five consecutive
trading day period (the “measurement period”) in which the “trading price” per $1,000 principal amount of such
series of Notes, as determined following a request by a holder or holders of such series of Notes in accordance with the procedures described
in the applicable Indenture, for each trading day of the measurement period was less than 98% of the product of the last reported sale
price of the Common Stock and the conversion rate of such series of Notes on each such trading day; (3) if the Company calls any or all
of such series of Notes for redemption, at any time prior to the close of business on the second scheduled trading day prior to the redemption
date (as defined in the applicable Indenture), but only with respect to the Notes of such series called (or deemed called as set forth
in the applicable Indenture) for redemption; or (4) upon the occurrence of specified corporate events as described in the applicable Indenture.
On or after November 15, 2030 until the close of business on the second scheduled trading day immediately preceding the maturity
date, holders may convert all or any portion of their Notes at the relevant conversion rate at any time irrespective of the foregoing
conditions.
The Company may not redeem either series of Notes
prior to March 20, 2029. The Company may redeem for cash all or any portion of either or both series of Notes, at the Company’s
option, on or after March 20, 2029 and on or before the 61st scheduled trading day immediately preceding the maturity date, if the last
reported sale price of the Common Stock has been at least 130% of the conversion price for the relevant series of Notes then in effect
for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day
of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption
at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus (1) in the case of the Series A Notes,
accrued and unpaid interest or (2) in the case of the Series B Notes, any accrued and unpaid special interest, in each case to, but excluding,
the redemption date. No sinking fund is provided for the Notes.
Holders of the Series B Notes may require the
Company to repurchase for cash all or part of their Series B Notes in principal amounts of $1,000 or a multiple thereof on March 15, 2027
(the “optional repurchase date”) at an optional repurchase price equal to 100% of the principal amount of the Series B Notes
to be repurchased, plus any accrued and unpaid special interest to, but excluding, the optional repurchase date.
If a fundamental change (as defined in the applicable
Indenture) occurs (other than an exempted fundamental change, as defined in the applicable Indenture), holders of each series of Notes
may require the Company to repurchase for cash all or any portion of their Notes at a repurchase price equal to 100% of the principal
amount of the Notes to be repurchased, plus (1) in the case of the Series A Notes, accrued and unpaid interest or (2) in the case
of the Series B Notes, any accrued and unpaid special interest, in each case to, but excluding, the relevant fundamental change repurchase
date.
The Notes are the Company’s senior unsecured
obligations and rank senior in right of payment to any of the Company’s indebtedness that is expressly subordinated in right of
payment to the Notes; equal in right of payment to any of the Company’s unsecured indebtedness that is not so subordinated, including
the Company’s 2.50% Convertible Senior Notes due 2027 (the “2027 Notes”); effectively junior in right of payment to
any of the Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally
junior to all indebtedness and other liabilities (including trade payables but excluding intercompany obligations and liabilities of a
type not required to be reflected on a balance sheet of such subsidiaries in accordance with GAAP) of the Company’s subsidiaries.
The events of default with respect to a series
of Notes, which may result in the acceleration of the maturity of such series of Notes, include, among other things, (1) default in any
payment of interest or special interest, as the case may be, on any Note of such series when due and payable and the default continues
for a period of 30 days; (2) default in the payment of principal of any Note of such series when due and payable at its stated maturity,
upon optional redemption, upon any required repurchase, upon declaration of acceleration or otherwise; (3) failure by the Company to comply
with its obligation to convert the Notes of such series in accordance with the relevant Indenture upon exercise of a holder’s conversion
right and such failure continues for a period of three business days; (4) failure by the Company to (x) give a fundamental change notice
or notice of a make-whole fundamental change (as defined in the applicable Indenture), in each case when due and such failure continues
for three business days, or (y) give notice of a specified corporate transaction (as defined in the applicable Indenture); (5) failure
by the Company to comply with its obligations in respect of any consolidation, merger or sale of assets; (6) failure by the Company for
60 days after written notice from the Trustee or the holders of at least 25% in aggregate principal amount of such series of Notes then
outstanding has been received to comply with any of the Company’s other agreements contained in such series of Notes or the relevant
Indenture; (7) default by the Company or any of its significant subsidiaries with respect to any mortgage, agreement or other instrument
under which there may be outstanding, or by which there may be secured or evidenced, any indebtedness for money borrowed (other than non-recourse
indebtedness) in excess of $100,000,000 (or its foreign currency equivalent) in the aggregate of the Company and/or any such significant
subsidiary, whether such indebtedness now exists or shall hereafter be created (x) resulting in such indebtedness becoming or being declared
due and payable or (y) constituting a failure to pay the principal or interest of any such indebtedness when due and payable (after the
expiration of all applicable grace periods) at its stated maturity, upon required repurchase, upon declaration of acceleration or otherwise,
and in the cases of clauses (x) and (y), such acceleration has not been rescinded or annulled or where such default is not cured or waived
within 30 days after notice to the Company by the Trustee or to the Company and the Trustee by holders of at least 25% of the aggregate
principal amount of Notes then outstanding, in accordance with the relevant Indenture; or (8) certain events of bankruptcy, insolvency,
or reorganization of the Company or any of its significant subsidiaries.
If an event of default with respect to a series
of Notes involving bankruptcy, insolvency or reorganization occurs and is continuing with respect to the Company, 100% of the principal
amount of such series of Notes then outstanding and accrued and unpaid interest or special interest, as the case may be, if any, on all
the outstanding Notes of such series will be automatically due and payable. If any other event of default occurs and is continuing, the
Trustee or the holders of at least 25% in aggregate principal amount of the then outstanding Notes of such series, by written notice to
the Company, may declare 100% of the principal amount of such series of Notes then outstanding and accrued and unpaid interest, or special
interest, as the case may be, if any, on the outstanding Notes of such series to be due and payable.
The Company estimates that the net proceeds from
the offering of the Notes will be approximately $975.7 million after deducting fees and estimated offering expenses.
The Company (1) used approximately $287.9 million
of the net proceeds from the sale of the Notes, as well as approximately $25 million cash on hand, and issued approximately 0.6 million
shares of Common Stock to repurchase approximately $285.9 million aggregate principal amount of the 2027 Notes through privately negotiated
transactions entered into concurrently with the pricing of the offering, (2) used approximately $25 million of the net proceeds from the
offering to repurchase concurrently with the closing of the offering, shares of Common Stock in privately negotiated transactions at a
price per share equal to $108.00 and (3) expects to use the remainder of the net proceeds from the offering for general corporate purposes.
Such share repurchases and the use of cash on hand were intended to offset a portion of the dilutive effect of the 2027 Notes.
The description of each Indenture and each series
of Notes is qualified in its entirety by reference to the text of the Series A Notes Indenture, the Form of Series A Note, the Series
B Notes Indenture and the Form of Series B Note, as applicable, copies of which are attached as Exhibits 4.1, 4.2, 4.3 and 4.4, respectively,
to this Current Report on Form 8-K and are incorporated herein by reference.